文献速递妇科

机器人辅助手术治疗子宫内膜癌在病态肥胖和极重度肥胖患者中是安全的

Robotic-assisted surgery for endometrial cancer is safe in morbidly and extremely morbidly obese patients.
PubMed 文献 · Gynecol Oncol · 2023-03-09

该回顾性研究纳入2012至2020年本中心BMI≥40 kg/m²的子宫内膜癌机器人手术患者185例,分为III级肥胖组(40-49 kg/m²,139例)和IV级肥胖组(≥50 kg/m²,46例)。结论认为该手术在两组中安全可行。

要点

  • 两组术中并发症、中转开腹率、再入院率、复发率及住院时间相似。
  • 3-4级术后并发症总体发生率低(2.7%),两组间无统计学差异。

核心结论

  • 机器人辅助手术治疗III级和IV级肥胖子宫内膜癌患者安全可行,并发症率低,肿瘤结局、中转开腹率、出血量、再入院率及住院时间相似。

研究设计与样本

  • 回顾性综述本中心2012至2020年因子宫内膜癌行机器人手术且BMI≥40 kg/m²的185例患者,分为III级肥胖组(40-49 kg/m²,139例)和IV级肥胖组(≥50 kg/m²,46例)。

主要发现

  • 术中并发症III级组1.4%,IV级组无,组间相似(P=1)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Obesity has risen to affect >25% of the Canadian population. Perioperative challenges with increased morbidity are encountered. We evaluated the outcome of robotic-assisted surgery for endometrial cancer (EC) in obese patients. METHODS: We retrospectively reviewed all robotic surgeries performed for EC in women with BMI ≥40 kg/m2, from 2012 to 2020 in our center. Patients were divided into 2 groups (class III: 40-49 kg/m2, class IV: ≥50 kg/m2). Complications and outcome were compared. RESULTS: 185 patients were included: 139 class III and 46 class IV. The main histology was endometrioid adenocarcinoma (70,5% of class III and 58,1% of class IV (p = 0,138)). The mean blood loss, overall sentinel node detection and median length of stay were similar in both groups. Six class III (4,3%) and 3 class IV (6,5%) patients required conversion to laparotomy due to poor surgical field exposure (p = 0,692). The rate of intraoperative complications was similar between the 2 groups (1.4% in class III vs none in class IV, p = 1). There were 10 class III (7,2%) and 10 class IV (21,7%) post-operative complications (p = 0.011), but most were grade 2 (3,6% in class III vs 13% in class IV, p = 0.029)). Grade 3 and 4 postoperative complications were low (2.7%) and not statistically different between the 2 groups. Readmission rate was low in both groups (4 in each group, p = 1.07). Recurrence occurred in 5,8% of class III and 4,3% of class IV patients (p = 1). CONCLUSION: Robotic-assisted surgery for EC in class III and class IV obese patients is a safe and feasible procedure, with low complication rate, similar oncologic outcome, conversion rate, blood loss, readmission rate and length of hospital stay.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Lechartier C, Bernard J, Renaud MC, et al. Robotic-assisted surgery for endometrial cancer is safe in morbidly and extremely morbidly obese patients. Gynecol Oncol. 2023. PMID: 36905768. doi:10.1016/j.ygyno.2023.02.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。